Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

High Response Rate and Acceptable Toxicity of R-P-Imvp-16/CBDCA for Relapsed or Refractory Aggressive B-Cell Lymphoma

Takuro Matsumoto, MD, Nobuhiko Nakamura, MD PhD, Yuhei Shibata, MD, Hiroshi Nakamura, MD, Ryoko Mabuchi, MD, Junichi Kitagawa, MD PhD, Nobuhiro Kanemura, MD PhD, Naoe Goto, MD PhD, Senji Kasahara, MD PhD, Hideko Goto, MD PhD, Kenji Fukuno, MD PhD, Takeshi Hara, MD PhD, Toshiki Yamada, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MD PhD, Masami Oyama, MD PhD, Koshiro Saito, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2014) 124 (21): 4418.

https://doi.org/10.1182/blood.V124.21.4418.4418

Published: 2014

Journal Articles

A Randomized Phase II/III Study of R-THP-Cop Vs R-CHOP for Patients Younger Than 70 Years with DLBCL

Naoe Goto, MD PhD, Takuro Matsumoto, MD, Yuhei Shibata, MD, Junichi Kitagawa, MD PhD, Nobuhiro Kanemura, MD PhD, Yoshikawa Takeshi, MDPhD, Senji Kasahara, MD PhD, Hideko Goto, MDPhD, Kenji Fukuno, MD, Takeshi Hara, MD PhD, Toshiki Yamada, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MDPhD, Koshiro Saito, MD PhD, Hisataka Moriwaki, Prof., Hisashi Tsurumi, MD PhD

Blood (2014) 124 (21): 3078.

https://doi.org/10.1182/blood.V124.21.3078.3078

Published: 2014

Journal Articles

Tryptophan Catabolism Is Associated with the Prognosis of Patients with De Novo Acute Myeloid Leukemia,

Hisashi Tsurumi, MD, PhD, Nobuhiro Kanemura, MD, PhD, Kenji Fukuno, MD, Junji Nagano, MD, Kengo Ogawa, MD, Soranobu Ninomiya, MD, Naoe Goto, MD, PhD, Senji Kasahara, MD, PhD, Takeshi Hara, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2011) 118 (21): 3541.

https://doi.org/10.1182/blood.V118.21.3541.3541

Published: 2011

Journal Articles

Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study.

Naoyuki Uchida, MD, Michihiro Hidaka, MD, Toru Sakura, MD, Toshihiro Miyamoto, MD, PhD, Tomoaki Fujisaki, MD, PhD, Tetsuya Eto, MD, PhD, Yoshinobu Maeda, MD, PhD, Kenji Fukuno, MD, PhD, Kana Matsumoto, PhD, Kunihiko Morita, PhD, Junji Kishimoto, PhD, Takahiro Fukuda, MD, PhD, Takanori Teshima, MD, PhD, Shuichi Taniguchi, MD, PhD, Shin-Ichiro Mori, MD, Mine Harada, MD, PhD

Blood (2010) 116 (21): 3477.

https://doi.org/10.1182/blood.V116.21.3477.3477

Published: 2010

Journal Articles

Expression of IDO (indoleamine 2,3-dioxygenase) In Blasts of Acute Myeloid Leukemia Patients Predicts Poor Clinical Outcome

Nobuhiko Nakamura, MD, Soranobu Ninomiya, MD, Takeshi Hara, MD, PhD, Kenji Fukuno, MD, Masato Hoshi, PhD, Nobuhiro Kanemura, MD, PhD, Naoe Goto, MD, PhD, Senji Kasahara, MD, PhD, Kuniaki Saito, PhD, Hisashi Tsurumi, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 4379.

https://doi.org/10.1182/blood.V116.21.4379.4379

Published: 2010

Journal Articles

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen

Satoshi Takahashi, Jun Ooi, Akira Tomonari, Takaaki Konuma, Nobuhiro Tsukada, Maki Oiwa-Monna, Kenji Fukuno, Michihiro Uchiyama, Kashiya Takasugi, Tohru Iseki, Arinobu Tojo, Takuhiro Yamaguchi, Shigetaka Asano

Blood (2006) 109 (3): 1322–1330.

https://doi.org/10.1182/blood-2006-04-020172

Published: 2006

Journal Articles

Clinical Outcomes of Cord Blood Transplantation from Unrelated Donors Comparable with Marrow or Blood Transplantation from Related Donors in Adults: A Single Institute Analysis.

Satoshi Takahashi, MD, Jun Ooi, MD, Akira Tomonari, MD, Takaaki Konuma, MD, Kenji Fukuno, MD, Nobuhiro Tsukada, MD, Maki Monna-Ooiwa, Takuhiro Yamaguchi, PhD, Arinobu Tojo, MD, Shigetaka Asano, MD

Blood (2005) 106 (11): 306.

https://doi.org/10.1182/blood.V106.11.306.306

Published: 2005

Journal Articles

Continuous Drip Infusion of Low Dose Cytrabine and Etoposide with Granulocyte Colony-Stimulating Factor for Elderly Acute Myeloid Leukemia Patients Hardly Tolerable Intensive Chemotherapy - Phase II Study.

Nobuhiro Kanemura, MD, Hisashi Tsurumi, MD, PhD, Takeshi Hara, MD, PhD, Senji Kasahara, MD, PhD, Naoe Goto, MD, Kenji Fukuno, MD, Toshiki Yamada, MD, PhD, Michio Sawada, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2005) 106 (11): 1858.

https://doi.org/10.1182/blood.V106.11.1858.1858

Published: 2005

NARROW

High Response Rate and Acceptable Toxicity of R-P-Imvp-16/CBDCA for Relapsed or Refractory Aggressive B-Cell Lymphoma

A Randomized Phase II/III Study of R-THP-Cop Vs R-CHOP for Patients Younger Than 70 Years with DLBCL

Tryptophan Catabolism Is Associated with the Prognosis of Patients with De Novo Acute Myeloid Leukemia,

Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study.

Expression of IDO (indoleamine 2,3-dioxygenase) In Blasts of Acute Myeloid Leukemia Patients Predicts Poor Clinical Outcome

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen

Clinical Outcomes of Cord Blood Transplantation from Unrelated Donors Comparable with Marrow or Blood Transplantation from Related Donors in Adults: A Single Institute Analysis.

Continuous Drip Infusion of Low Dose Cytrabine and Etoposide with Granulocyte Colony-Stimulating Factor for Elderly Acute Myeloid Leukemia Patients Hardly Tolerable Intensive Chemotherapy - Phase II Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only